1Harman KE,Seed PT,Gratian MJ,et al.The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.Br J Dermatol,2001,144:775-780.
2Little BB. Immunosuppressant therapy during gestation. Semin Perinatol,1997,21:143-148.
3Beckers RCY, Brand A,Verneer BJ,et al. Adjuvanthigh dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid:experience in six patlennts.Br Jdermatol,1995,133:289-293.
4Kardos M, Levine D, Curcan HM, et al. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomesj]]. Obstet Gynecol Surv, 2009, 64( n ? 739-749.
5Bialynicki-Birula R, Dmochowski M, Maj J, et al. Pregnancytriggered maternal pemphigus vulgaris with persistent gingival lesions[J]. Acta Dermatovenerol Croat, 2011, 19(3): 170-175.
6Drenovska K, Darlenski R, Kazandjieva J, et al. Pemphigus vulgaris and pregnancy[J]. Skinmed, 2010,8(3): 144-149.
7Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation [J]. Semin Arthritis Rheum, 2005, 35 (2): 112-121.
8U gajin T, Yahara H, Moriyama Y, et al. Two siblings with neonatal pemphigus vulgaris associated with mild maternal diseasej J']. Br J Dermatol, 2007, 157( 1): 192-194.
